A detailed history of Cascade Investment Group, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Cascade Investment Group, Inc. holds 4,000 shares of TECH stock, worth $286,600. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$286,600
Previous $309 Million 8.77%
% of portfolio
0.21%
Previous 0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 27, 2023

BUY
$80.67 - $352.29 $322,680 - $1.41 Million
4,000 New
4,000 $332 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.81B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cascade Investment Group, Inc. Portfolio

Follow Cascade Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Group, Inc. with notifications on news.